header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Foot & Ankle

SHORT TERM OUTCOMES OF MOBILITY TOTAL ANKLE ARTHROPLASTY

British Orthopaedic Foot & Ankle Society (BOFAS)



Abstract

Introduction

This project reports differences in outcome measures after total ankle arthroplasty (TAA) for patients with Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Post-traumatic Osteoarthritis (PTOA).

Materials and Methods

Patients who underwent TAA between March 2006 and May 2010 were included. Assessments including questionnaires (height, weight, Foot and Ankle Outcome Score, SF-36) and American Orthopaedic Foot and Ankle Score (AOFAS) were completed pre-operatively, 3, 6, and 12-months after surgery. Analyses of outcomes by diagnosis were adjusted for age, gender and BMI.

Results

A total of 114 TAAs performed for OA (59), PTOA (35), and RA (20). OA patients were significantly older than PTOA (64 vs. 56, p=0.002) and more likely to be male than either RA or PTOA (78% vs. 35% and 54%, p=0.001). PTOA and OA patients had significantly higher BMI (30 and 29) than RA (25, p=0.002).

There were significant improvements at 12-months for AOFAS scores for all groups 31 to 75 (OA), 29 to 77 (PTOA) and 24 to 80 (RA). No significant difference in AOFAS scores between the groups at any time.

Despite no significant difference in preoperative patient-reported measures between groups, OA patients reported worse ankle-related pain and function outcomes compared to the RA and PTOA patients. This trend increases at each follow-up period and was significant at 1-year for pain (p=0.03) and function (p=0.018). PTOA patients had significantly better SF-36 scores at 1 year (p<0.05 for 5 domains).

Conclusion

These early results comparing outcomes by diagnostic groups demonstrate that PTOA and RA patients have superior outcomes compared to patients with primary OA.